FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044147635> ?p ?o ?g. }

• W2044147635 endingPage "75" @default.
• W2044147635 startingPage "66" @default.
• W2044147635 abstract "Clinical application of recombinant tissue plasminogen activator (rtPA) for stroke is limited by hemorrhagic transformation, which narrows rtPA’s therapeutic window. In addition, mounting evidence indicates that rtPA is potentially neurotoxic if it traverses a compromised blood brain barrier. Here, we demonstrated that pyruvate protects cultured HT22 neuronal and primary microvascular endothelial cells co-cultured with primary astrocytes from oxygen glucose deprivation (OGD)/reoxygenation stress and rtPA cytotoxicity. After 3 or 6 h OGD, cells were reoxygenated with 11 mmol/L glucose±pyruvate (8 mmol/L) and/or rtPA (10 µg/ml). Measured variables included cellular viability (calcein AM and annexin-V/propidium iodide), reactive oxygen species (ROS; mitosox red and 2′,7′-dichlorofluorescein diacetate), NADPH, NADP+ and ATP contents (spectrophotometry), matrix metalloproteinase-2 (MMP2) activities (gelatin zymography), and cellular contents of MMP2, tissue inhibitor of metalloproteinase-2 (TIMP2), and phosphor-activation of anti-apoptotic p70s6 kinase, Akt and Erk (immunoblot). Pyruvate prevented the loss of HT22 cells after 3 h OGD±rtPA. After 6 h OGD, rtPA sharply lowered cell viability; pyruvate dampened this effect. Three hours OGD and 4 h reoxygenation with rtPA increased ROS formation by about 50%. Pyruvate prevented this ROS formation and doubled cellular NADPH/NADP+ ratio and ATP content. In endothelial cell monolayers, 3 h OGD and 24 h reoxygenation increased FITC-dextran leakage, indicating disruption of intercellular junctions. Although rtPA exacerbated this effect, pyruvate prevented it while sharply lowering MMP2/TIMP2 ratio and increasing phosphorylation of p70s6 kinase, Akt and Erk. Pyruvate protects neuronal cells and microvascular endothelium from hypoxia-reoxygenation and cytotoxic action of rtPA while reducing ROS and activating anti-apoptotic signaling. These results support the proposed use of pyruvate as an adjuvant to dampen the side effects of rtPA treatment, thereby extending rtPA’s therapeutic window." @default.
• W2044147635 created "2016-06-24" @default.
• W2044147635 creator A5007860884 @default.
• W2044147635 creator A5019163780 @default.
• W2044147635 creator A5022189337 @default.
• W2044147635 creator A5030624013 @default.
• W2044147635 creator A5058129833 @default.
• W2044147635 creator A5065322806 @default.
• W2044147635 date "2013-09-01" @default.
• W2044147635 modified "2023-10-03" @default.
• W2044147635 title "Pyruvate minimizes rtPA toxicity from in vitro oxygen-glucose deprivation and reoxygenation" @default.
• W2044147635 cites W1540258377 @default.
• W2044147635 cites W1790261501 @default.
• W2044147635 cites W1964835675 @default.
• W2044147635 cites W1977566591 @default.
• W2044147635 cites W1988345639 @default.
• W2044147635 cites W1994428345 @default.
• W2044147635 cites W2004229929 @default.
• W2044147635 cites W2012473171 @default.
• W2044147635 cites W2016165623 @default.
• W2044147635 cites W2035027410 @default.
• W2044147635 cites W2037996523 @default.
• W2044147635 cites W2045450230 @default.
• W2044147635 cites W2050938999 @default.
• W2044147635 cites W2053778276 @default.
• W2044147635 cites W2056282618 @default.
• W2044147635 cites W2056553691 @default.
• W2044147635 cites W2063659572 @default.
• W2044147635 cites W2065031308 @default.
• W2044147635 cites W2071190017 @default.
• W2044147635 cites W2080482523 @default.
• W2044147635 cites W2103320383 @default.
• W2044147635 cites W2113220524 @default.
• W2044147635 cites W2118510869 @default.
• W2044147635 cites W2123656924 @default.
• W2044147635 cites W2128578138 @default.
• W2044147635 cites W2137499753 @default.
• W2044147635 cites W2152300854 @default.
• W2044147635 cites W2157368934 @default.
• W2044147635 cites W2158589550 @default.
• W2044147635 cites W2159233098 @default.
• W2044147635 cites W2592271040 @default.
• W2044147635 doi "https://doi.org/10.1016/j.brainres.2013.07.029" @default.
• W2044147635 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4007160" @default.
• W2044147635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23891792" @default.
• W2044147635 hasPublicationYear "2013" @default.
• W2044147635 type Work @default.
• W2044147635 sameAs 2044147635 @default.
• W2044147635 citedByCount "12" @default.
• W2044147635 countsByYear W20441476352014 @default.
• W2044147635 countsByYear W20441476352015 @default.
• W2044147635 countsByYear W20441476352016 @default.
• W2044147635 countsByYear W20441476352017 @default.
• W2044147635 countsByYear W20441476352018 @default.
• W2044147635 countsByYear W20441476352020 @default.
• W2044147635 countsByYear W20441476352021 @default.
• W2044147635 countsByYear W20441476352023 @default.
• W2044147635 crossrefType "journal-article" @default.
• W2044147635 hasAuthorship W2044147635A5007860884 @default.
• W2044147635 hasAuthorship W2044147635A5019163780 @default.
• W2044147635 hasAuthorship W2044147635A5022189337 @default.
• W2044147635 hasAuthorship W2044147635A5030624013 @default.
• W2044147635 hasAuthorship W2044147635A5058129833 @default.
• W2044147635 hasAuthorship W2044147635A5065322806 @default.
• W2044147635 hasBestOaLocation W20441476352 @default.
• W2044147635 hasConcept C10730799 @default.
• W2044147635 hasConcept C153911025 @default.
• W2044147635 hasConcept C181199279 @default.
• W2044147635 hasConcept C185592680 @default.
• W2044147635 hasConcept C190283241 @default.
• W2044147635 hasConcept C20251656 @default.
• W2044147635 hasConcept C2775934118 @default.
• W2044147635 hasConcept C2779964046 @default.
• W2044147635 hasConcept C2780854706 @default.
• W2044147635 hasConcept C31573885 @default.
• W2044147635 hasConcept C48349386 @default.
• W2044147635 hasConcept C53227056 @default.
• W2044147635 hasConcept C55493867 @default.
• W2044147635 hasConcept C62231903 @default.
• W2044147635 hasConcept C75217442 @default.
• W2044147635 hasConcept C86803240 @default.
• W2044147635 hasConcept C88099638 @default.
• W2044147635 hasConcept C9506865 @default.
• W2044147635 hasConcept C98274493 @default.
• W2044147635 hasConceptScore W2044147635C10730799 @default.
• W2044147635 hasConceptScore W2044147635C153911025 @default.
• W2044147635 hasConceptScore W2044147635C181199279 @default.
• W2044147635 hasConceptScore W2044147635C185592680 @default.
• W2044147635 hasConceptScore W2044147635C190283241 @default.
• W2044147635 hasConceptScore W2044147635C20251656 @default.
• W2044147635 hasConceptScore W2044147635C2775934118 @default.
• W2044147635 hasConceptScore W2044147635C2779964046 @default.
• W2044147635 hasConceptScore W2044147635C2780854706 @default.
• W2044147635 hasConceptScore W2044147635C31573885 @default.
• W2044147635 hasConceptScore W2044147635C48349386 @default.
• W2044147635 hasConceptScore W2044147635C53227056 @default.
• W2044147635 hasConceptScore W2044147635C55493867 @default.
• W2044147635 hasConceptScore W2044147635C62231903 @default.

• next